Higher doses reached that plateau later in the trial. In a 112-week step-down trial, participants maintained 21.9% loss on the top dose, 16.6% after stepping down to 5 mg, and 9.9% on placebo
Visual inspection is your first check
Microneedling creates micro-channels in the skin, enhancing the penetration of GHK-Cu and potentially amplifying its ability to stimulate collagen production and remodel scar tissue
Key accelerators include: Mitochondrial dysfunction: Leading to reduced energy output and increased reactive oxygen species (ROS)
Contrarily, generally no new vessels grew in BPC 157treated rats (i.e., those that did form in the limbus did not make contact with the penetrated area) (Masnec et al., 2015), showing that BPC 157 therapy may acknowledge also the angiogenic privilege of the corneal avascularity as essential for corneal wound healing (Tshionyi et al., 2012)